Overview Fundamentals API Earnings EOD API Sample Code Pricing

CONTEXT THERAPEUT.DL-001 (6K9 F) stock market data APIs

€2.04 0.11(5.7%) as of October 30, 2024
Price chart is built with Anychart

Context Therapeutics Inc., a biopharmaceutical company, develops products for the treatment of solid tumors. Its lead program candidate is CTIM-76, an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. The company has a collaboration and licensing agreement with Integral Molecular, Inc. for the development of a CLDN6 bispecific monoclonal antibody for cancer therapy. Context Therapeutics Inc. was incorporated in 2015 and is headquartered in Philadelphia, Pennsylvania.

CONTEXT THERAPEUT.DL-001 Financial Data Overview

1.93
2.04
-
2.04
1.93
0.685-2.4
155 M
74 998 K
0
2.272
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: '6K9',
Type: 'Common Stock',
Name: 'CONTEXT THERAPEUT.DL-001',
Exchange: 'F',
CurrencyCode: 'EUR',
CurrencyName: 'Euro',
CurrencySymbol: '€',
CountryName: 'Germany',
CountryISO: 'DE',
OpenFigi: NULL,
ISIN: NULL,
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
CUSIP: NULL,
}

CONTEXT THERAPEUT.DL-001 Fundamental Data is available in our Financial Data APIs

  • Net Revenue 0
  • EBITDA -20 014 956
  • Earnings Per Share -0.89
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get CONTEXT THERAPEUT.DL-001 Earnings via APIs

  • Latest Release NaN
  • EPS/Forecast NaN

Get CONTEXT THERAPEUT.DL-001 End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com